PTGX - President and CEO at Protagonist Therapeutics Exercises Options Worth $87K | Benzinga
Dinesh V. Patel, Ph.D., President and CEO at Protagonist Therapeutics (NASDAQ:PTGX), reported a large exercise of company stock options on October 19, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Ph.D., President and CEO at Protagonist Therapeutics, a company in the Health Care sector, just exercised stock options worth 6,000 shares of PTGX stock with an exercise price of $4.21.
Protagonist Therapeutics shares are trading up 0.83% at $14.53 at the time of this writing on Friday morning. Since the current price is $14.53, this makes Ph.D.'s 6,000 shares worth $87,180.